2 TWENTYFOURSEVENBIOPHARMA Issue 3 / October 2025 SUNRESIN 54 Innovation in SPPS: A new MBH Br resin for manufacturing C-terminal acid peptides, an alternative to Wang and CTC resins SYNGENE 58 Translational and clinical integration is reshaping early-phase drug development HAS-CERBIOS 60 Inside HAS-Cerbios: Building a unique CDMO FLAMMA 64 Why innovator companies need to take control of their supply chains CONTENTS 1 WELCOME NEWS 4 VERANOVA 34 Realizing the potential of ADCs DIGITALISATION 38 Resilient, digital, diversified: The pharma supply chain of 2030 GRIFOLS 42 Interview LONZA 46 Data-driven drug development: Accelerating small molecule success in early phase AXPLORA 50 Mastering complexity - Innovative strategies for efficient ADC payload manufacturing and bioconjugation MARTA SERRA Quality & Regulatory Director GRIFOLS GRIFOLS Interview 42
RkJQdWJsaXNoZXIy MjY2OTA4MA==